Tag: Insurance: Medicare
Medicare Patients With MS Face Higher Out-of-Pocket Rx Costs
Projected cumulative out-of-pocket spending for disease-modifying therapies for 2019 was $6,894
Earlier Vascular Access Seen in Insured Dialysis Patients
Patients with Medicare, Medicaid more likely to use arteriovenous fistula, graft by fourth dialysis month
Trump Administration Announces Plan to Cut Drug Prices
HHS study shows Medicare pays 80 percent more than other countries for certain prescription drugs
2006 to 2015 Saw Decrease in Medicare Beneficiary ICU Use
Admission rates to the ICU significantly decreased, with large variations seen by state
Spending Often Persists in High-Cost Medicare-Medicaid Eligible
Most of cost is related to long-term care, little tied to potentially preventable hospitalizations
Physician-Group ACOs Generate Medicare Savings
Savings grow with longer participation and are significantly higher than hospital-integrated ACOs
Simplifying Medicare Plan Finder Improves Plan Selection
Simplifying Plan Finder results in selection of lower-cost plans with no decrease in plan quality
Guideline-Discordant Prostate Cancer Imaging Up With Medicare
Patients in VA and Medicare group, VA-only group less likely to receive guideline-discordant imaging
Out-of-Pocket Costs Similar for Infliximab, Infliximab-Dyyb
Mean total costs per eight-week prescription and annually modestly lower for infliximab biosimilar
Medicare, Med Advantage Health Care Use Differs Regionally
Variation in skilled nursing facility, hospital care up in Medicare Advantage versus traditional Medicare
